Total Liabilities - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Pharma
Total Liabilities Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Total Liabilities
â‚©1T
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
22%
Yuhan Corp
KRX:000100
Total Liabilities
â‚©834.9B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
11%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Liabilities
â‚©439.5B
CAGR 3-Years
54%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Liabilities
â‚©919.3B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Liabilities
â‚©214.9B
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
13%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Liabilities
â‚©258.8B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
2%

See Also

What is Daewoong Pharma's Total Liabilities?
Total Liabilities
1T KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Total Liabilities amounts to 1T KRW.

What is Daewoong Pharma's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
22%

Over the last year, the Total Liabilities growth was 5%. The average annual Total Liabilities growth rates for Daewoong Pharma have been 6% over the past three years , 7% over the past five years , and 22% over the past ten years .

Back to Top